Literature DB >> 10680817

Positive CSF HSV PCR in patients with GBM: a note of caution.

S S McDermott1, P F McDermott, J Skare, M Glantz, T W Smith, N S Litofsky, L D Recht.   

Abstract

Because two patients with temporal lobe glioblastomas had herpes simplex (HSV) DNA detected in CSF using PCR at the time of their presentation, we reviewed our laboratory's experience and performed PCR on a bank of 159 frozen CSF samples from patients with glioblastoma multiforme and other neurologic disorders. Based on the inability to detect HSV in any other tumor sample, we conclude that the positive HSV PCR in our two index patients most likely represented false-positive results. A diagnosis of HSE should not be made by PCR alone when the clinical presentation is atypical.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680817     DOI: 10.1212/wnl.54.3.746

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Herpes simplex encephalitis in patients with cancer.

Authors:  Jerome J Graber; Marc K Rosenblum; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

2.  Herpes Simplex Encephalitis in Adults and Older Children.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2005-03       Impact factor: 3.972

3.  Clinical utility of a nested nucleic acid amplification format in comparison to viral culture for the diagnosis of mucosal herpes simplex infection in a genitourinary medicine setting.

Authors:  P V Coyle; H J O'Neill; C McCaughey; D E Wyatt; M O McBride
Journal:  BMC Infect Dis       Date:  2001-08-21       Impact factor: 3.090

4.  A Rare Case of Concurrent Herpes Simplex Encephalitis and Glioblastoma Multiforme.

Authors:  Parag Sayal; Arif Zafar; Robin Highley
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

5.  Molecular Techniques in the Diagnosis of Central Nervous System Infections.

Authors:  Hong-Zhou Lu; Karen C. Bloch; Yi-Wei Tang
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.